Frontlight ResearchEarly access
Trial site
Alaska Oncology and Hematology
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Chronic myeloid leukaemia2 trials
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Myeloproliferative neoplasms1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 312 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting8 trials
- Active, not recruiting3 trials
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Amgen2 trials
- Gilead Sciences2 trials
- Novartis Pharmaceuticals2 trials
- Celgene1 trial
- Eli Lilly and Company1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer6 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026